A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...

"We don't see it super commonly, but it is definitely out there and worth being concerned about," said Allison Bray, with San ...

In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

Vast Data doesn’t chunk files in memory but uses an exabyte-scale solid-state disk fabric to deliver “millisecond latency at ...